Cargando…

Is multiple session of intralesional bleomycin mandatory for complete resolution of macrocystic lymphatic malformation?

BACKGROUND: Intralesional bleomycin scelro-therapy has become a favored line of treatment for macrocystic lymphatic malformations. However the need for multiple sessions is a drawback associated with this treatment modality. Our aim is to document whether multiple session of intra- lesional sclero-t...

Descripción completa

Detalles Bibliográficos
Autores principales: Upadhyaya, Vijai Datta, Bhatnagar, Ankur, Kumar, Basant, Neyaz, Zafar, Kishore, J. S., Sthapak, Eti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992947/
https://www.ncbi.nlm.nih.gov/pubmed/29928081
http://dx.doi.org/10.4103/ijps.IJPS_154_17
_version_ 1783330138351468544
author Upadhyaya, Vijai Datta
Bhatnagar, Ankur
Kumar, Basant
Neyaz, Zafar
Kishore, J. S.
Sthapak, Eti
author_facet Upadhyaya, Vijai Datta
Bhatnagar, Ankur
Kumar, Basant
Neyaz, Zafar
Kishore, J. S.
Sthapak, Eti
author_sort Upadhyaya, Vijai Datta
collection PubMed
description BACKGROUND: Intralesional bleomycin scelro-therapy has become a favored line of treatment for macrocystic lymphatic malformations. However the need for multiple sessions is a drawback associated with this treatment modality. Our aim is to document whether multiple session of intra- lesional sclero-therapy is necessary for complete resolution of cystic lymphatic malformation. METHOD: Intralesional bleomycin under Ultrasound guidance was used for macrocystic lymphangioma at concentration of 3mg/ml but not exceeding the total dose (1mg/kg) body weight for single session or cumulative dose of 5mg/kg. In all cases intralesional sclerosant (ILS) was installed under proper aseptic precaution in operation theatre in general anesthesia or sedation depending on the site or size of lesion and age of the patient. Age of patients at the time of enrolment in study ranged from 3 months to 18 years. Clinical examination was the main stay of diagnosis which was supplemented by USG and/or computed tomography. Compression of the lesion site was done for few hours wherever it was possible after the ILS session. RESULT: A total of 21 patients included in our study. The age ranged from 3 months to 18 years. Male to female ratio was 8:13. The most common site of involvement was neck and axilla followed by anterior chest wall and nape of the neck. Complete resolution after single session was observed in 90.5% cases where as surgery was required in 9.5% case. Major complication was observed in one patient, who had intralesional bleeding which was managed conservatively. Transient pain and fever was observed in 23.8% of cases. Only two patient required surgical intervention where one had persistent subcutaneous fibrotic nodule and other one did not respond to ILS. CONCLUSION: Intralesional bleomycin is an effective treatment for macrocystic lesion, and complete resolution may be achieved by single session of ILS if proper principle are followed.
format Online
Article
Text
id pubmed-5992947
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-59929472018-06-20 Is multiple session of intralesional bleomycin mandatory for complete resolution of macrocystic lymphatic malformation? Upadhyaya, Vijai Datta Bhatnagar, Ankur Kumar, Basant Neyaz, Zafar Kishore, J. S. Sthapak, Eti Indian J Plast Surg Original Article BACKGROUND: Intralesional bleomycin scelro-therapy has become a favored line of treatment for macrocystic lymphatic malformations. However the need for multiple sessions is a drawback associated with this treatment modality. Our aim is to document whether multiple session of intra- lesional sclero-therapy is necessary for complete resolution of cystic lymphatic malformation. METHOD: Intralesional bleomycin under Ultrasound guidance was used for macrocystic lymphangioma at concentration of 3mg/ml but not exceeding the total dose (1mg/kg) body weight for single session or cumulative dose of 5mg/kg. In all cases intralesional sclerosant (ILS) was installed under proper aseptic precaution in operation theatre in general anesthesia or sedation depending on the site or size of lesion and age of the patient. Age of patients at the time of enrolment in study ranged from 3 months to 18 years. Clinical examination was the main stay of diagnosis which was supplemented by USG and/or computed tomography. Compression of the lesion site was done for few hours wherever it was possible after the ILS session. RESULT: A total of 21 patients included in our study. The age ranged from 3 months to 18 years. Male to female ratio was 8:13. The most common site of involvement was neck and axilla followed by anterior chest wall and nape of the neck. Complete resolution after single session was observed in 90.5% cases where as surgery was required in 9.5% case. Major complication was observed in one patient, who had intralesional bleeding which was managed conservatively. Transient pain and fever was observed in 23.8% of cases. Only two patient required surgical intervention where one had persistent subcutaneous fibrotic nodule and other one did not respond to ILS. CONCLUSION: Intralesional bleomycin is an effective treatment for macrocystic lesion, and complete resolution may be achieved by single session of ILS if proper principle are followed. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC5992947/ /pubmed/29928081 http://dx.doi.org/10.4103/ijps.IJPS_154_17 Text en Copyright: © 2018 Indian Journal of Plastic Surgery http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Upadhyaya, Vijai Datta
Bhatnagar, Ankur
Kumar, Basant
Neyaz, Zafar
Kishore, J. S.
Sthapak, Eti
Is multiple session of intralesional bleomycin mandatory for complete resolution of macrocystic lymphatic malformation?
title Is multiple session of intralesional bleomycin mandatory for complete resolution of macrocystic lymphatic malformation?
title_full Is multiple session of intralesional bleomycin mandatory for complete resolution of macrocystic lymphatic malformation?
title_fullStr Is multiple session of intralesional bleomycin mandatory for complete resolution of macrocystic lymphatic malformation?
title_full_unstemmed Is multiple session of intralesional bleomycin mandatory for complete resolution of macrocystic lymphatic malformation?
title_short Is multiple session of intralesional bleomycin mandatory for complete resolution of macrocystic lymphatic malformation?
title_sort is multiple session of intralesional bleomycin mandatory for complete resolution of macrocystic lymphatic malformation?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5992947/
https://www.ncbi.nlm.nih.gov/pubmed/29928081
http://dx.doi.org/10.4103/ijps.IJPS_154_17
work_keys_str_mv AT upadhyayavijaidatta ismultiplesessionofintralesionalbleomycinmandatoryforcompleteresolutionofmacrocysticlymphaticmalformation
AT bhatnagarankur ismultiplesessionofintralesionalbleomycinmandatoryforcompleteresolutionofmacrocysticlymphaticmalformation
AT kumarbasant ismultiplesessionofintralesionalbleomycinmandatoryforcompleteresolutionofmacrocysticlymphaticmalformation
AT neyazzafar ismultiplesessionofintralesionalbleomycinmandatoryforcompleteresolutionofmacrocysticlymphaticmalformation
AT kishorejs ismultiplesessionofintralesionalbleomycinmandatoryforcompleteresolutionofmacrocysticlymphaticmalformation
AT sthapaketi ismultiplesessionofintralesionalbleomycinmandatoryforcompleteresolutionofmacrocysticlymphaticmalformation